The Transcription Factor Creb is Involved in Sorafenib-Inhibited Renal Cancer Cell Proliferation, Migration and Invasion
Our previous reports showed that the cyclic-AMP-response element-binding protein (CREB) served as a proto-oncogene in the process of tumorigenesis and mediated the growth and metastatic activity of renal cancer cells. Our study, therefore, explored the role of CREB in sorafenib- -inhibited cell prol...
Main Authors: | Huang Shuaishuai, Cui Pinger, Lin Shuangxia, Yao Xuping, Wang Xue, Ren Yu, Weng Guobin |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-12-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2018-0033 |
Similar Items
-
CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET
by: Shuyang Wang, et al.
Published: (2020-08-01) -
Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy?
by: Huang Y, et al.
Published: (2019-01-01) -
Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma
by: Michael Friedrich, et al.
Published: (2020-09-01) -
CREB Regulates AChE-R-Induced Proliferation of Human Glioblastoma Cells
by: Chava Perry, et al.
Published: (2004-05-01) -
Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
by: Agnieszka Karbownik, et al.
Published: (2020-06-01)